ATG5 and acute myeloid leukemia: In conclusion, this study demonstrates that CELF1 is a novel AML chemotherapy resistance-related protein that directly targets and regulates ATG5 mRNA stability, promoting its expression and triggering protective autophagy-mediated drug resistance in cells.